MYHEP ALL 400 MG/100 MG 28 TABLETS | Sofosbuvir & Velpatasvir
MYHEP ALL 400 MG/100 MG 28 TABLETS contain Sofosbuvir 400 mg and Velpatasvir 100 mg, a prescription antiviral combination used for the treatment of chronic hepatitis C virus (HCV) infection.
MYHEP ALL 400 MG/100 MG 28 TABLETS
MYHEP ALL 400 MG/100 MG TABLETS (Sofosbuvir 400 mg + Velpatasvir 100 mg): Comprehensive Guide and Benefits
Introduction to MYHEP ALL 400 MG/100 MG TABLETS
Pan-Genotypic Antiviral Medicine for Chronic Hepatitis C
MYHEP ALL 400 MG/100 MG 28 TABLETS contain Sofosbuvir 400 mg and Velpatasvir 100 mg, a prescription direct-acting antiviral (DAA) combination. It is used for the treatment of chronic hepatitis C virus (HCV) infection across all major HCV genotypes. The combination works by blocking viral replication, helping eliminate the hepatitis C virus from the body.
Prescription Status: Prescription-only medicine. Use only under the supervision of a qualified healthcare professional.
Key Benefits of MYHEP ALL 400 MG/100 MG TABLETS
Pan-genotypic antiviral treatment for chronic HCV infection.
Combines two direct-acting antiviral agents in a single tablet.
Helps suppress viral replication through complementary mechanisms.
Convenient once-daily oral dosing.
Suitable for treatment under specialist medical supervision.
Composition
Active Ingredients:
Sofosbuvir – 400 mg
Velpatasvir – 100 mg
Dosage Form:
Film-Coated Tablet
Pack Size:
1 Bottle of 28 Tablets
Drug Class
Direct-Acting Antiviral (DAA)
NS5B Polymerase Inhibitor + NS5A Inhibitor
Therapeutic Category
Antiviral Medicine
How MYHEP ALL 400 MG/100 MG Works
Sofosbuvir inhibits the NS5B RNA-dependent RNA polymerase, while Velpatasvir inhibits the NS5A protein required for viral replication and assembly. Together, they block multiple stages of the hepatitis C virus life cycle, preventing viral multiplication.
Usage Instructions
Take MYHEP ALL 400 MG/100 MG TABLETS exactly as prescribed by your doctor.
Swallow the tablet whole with water.
It may be taken with or without food.
Take one tablet at the same time each day.
Complete the full treatment course as advised by your healthcare provider.
Medicinal Advantages
Pan-Genotypic Coverage
Effective against all major hepatitis C virus genotypes.
Dual Antiviral Action
Combines two complementary antiviral agents for enhanced viral suppression.
Convenient Once-Daily Therapy
Simplifies treatment with a single daily tablet.
Established Direct-Acting Antiviral Regimen
Widely recommended as a modern treatment option for chronic hepatitis C under specialist supervision.
Mechanism of Action
Sofosbuvir acts as a nucleotide analogue that inhibits the viral NS5B polymerase, while Velpatasvir blocks the NS5A replication complex, resulting in inhibition of viral RNA replication and viral particle formation.
Off-Label Uses
Healthcare professionals may prescribe this combination for conditions outside its approved indications when clinically appropriate.
Expert Advice
Take the medicine exactly as prescribed.
Do not miss doses during treatment.
Inform your healthcare provider about all medicines and supplements you are taking.
Attend scheduled follow-up visits and laboratory monitoring.
Complete the prescribed treatment duration for optimal results.
Precautions
Use only under medical supervision.
Inform your doctor if you have liver disease, kidney disease, or hepatitis B infection.
Consult your doctor before use during pregnancy or breastfeeding.
Inform your healthcare provider about all prescription and non-prescription medicines before starting therapy.
Storage Instructions
Store below 30°C.
Keep the tablets in the original bottle.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What are the active ingredients in MYHEP ALL 400 MG/100 MG TABLETS?
A: Each tablet contains Sofosbuvir 400 mg and Velpatasvir 100 mg.
Q: What drug class does MYHEP ALL belong to?
A: It belongs to the Direct-Acting Antiviral (DAA) class and combines an NS5B polymerase inhibitor with an NS5A inhibitor.
Q: Can MYHEP ALL be taken with food?
A: Yes. It may be taken with or without food as directed by your healthcare professional.
Q: Is MYHEP ALL a prescription medicine?
A: Yes. MYHEP ALL 400 MG/100 MG TABLETS are available only on prescription and should be used under specialist medical supervision.
Q: How should MYHEP ALL TABLETS be stored?
A: Store below 30°C in the original container, protected from moisture and direct sunlight.
Product Tags
MYHEP ALL 400 MG/100 MG 28 TABLETS, Sofosbuvir 400 mg, Velpatasvir 100 mg, Direct-Acting Antiviral, DAA, NS5B Polymerase Inhibitor, NS5A Inhibitor, Chronic Hepatitis C Medicine, Prescription Antiviral, HCV Treatment.
